- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 235/06 - BenzimidazolesHydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
Patent holdings for IPC class C07D 235/06
Total number of patents in this class: 452
10-year publication summary
|
29
|
31
|
30
|
22
|
28
|
23
|
25
|
24
|
21
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Array BioPharma Inc. | 446 |
15 |
| Probiodrug AG | 59 |
10 |
| LG Chem, Ltd. | 17929 |
9 |
| Alexion Pharma International Operations Limited | 35 |
9 |
| Agios Pharmaceuticals, Inc | 225 |
6 |
| BioAge Labs, Inc. | 45 |
6 |
| Vivoryon Therapeutics N.V. | 48 |
6 |
| F. Hoffmann-La Roche AG | 7819 |
5 |
| Allergan, Inc. | 2162 |
5 |
| Biosplice Therapeutics, Inc. | 160 |
5 |
| Novartis AG | 10251 |
4 |
| AstraZeneca AB | 2819 |
4 |
| Bayer Pharma AG | 1009 |
4 |
| Abbvie Inc. | 1824 |
4 |
| Mayo Foundation for Medical Education and Research | 3386 |
4 |
| Nippon Shinyaku Co., Ltd. | 323 |
4 |
| Suven Life Sciences Limited | 138 |
4 |
| University of Tennessee Research Foundation | 764 |
4 |
| The Wistar Institute of Anatomy and Biology | 483 |
4 |
| Regenacy Pharmaceuticals, LLC | 26 |
4 |
| Other owners | 336 |